| OXCARBAZEPINE |
218442 |
002 |
ANDA |
OXCARBAZEPINE |
TABLET;EXTENDED RELEASE |
300MG |
No
|
No
|
2025/01/08
(TA)
|
--
|
BIOCON PHARMA LTD |
None (Tentative Approval) |
| OXCARBAZEPINE |
218442 |
003 |
ANDA |
OXCARBAZEPINE |
TABLET;EXTENDED RELEASE |
600MG |
No
|
No
|
2025/01/08
(TA)
|
--
|
BIOCON PHARMA LTD |
None (Tentative Approval) |
| OXCARBAZEPINE |
219241 |
001 |
ANDA |
OXCARBAZEPINE |
TABLET, EXTENDED RELEASE;ORAL |
150MG |
No
|
No
|
2025/04/30
|
2025/04/30
|
AUROBINDO PHARMA LTD |
Discontinued |
| OXCARBAZEPINE |
219241 |
002 |
ANDA |
OXCARBAZEPINE |
TABLET, EXTENDED RELEASE;ORAL |
300MG |
No
|
No
|
2025/04/30
|
2025/04/30
|
AUROBINDO PHARMA LTD |
Discontinued |
| OXCARBAZEPINE |
219241 |
003 |
ANDA |
OXCARBAZEPINE |
TABLET, EXTENDED RELEASE;ORAL |
600MG |
No
|
No
|
2025/04/30
|
2025/04/30
|
AUROBINDO PHARMA LTD |
Discontinued |
| OXCARBAZEPINE |
218724 |
002 |
ANDA |
OXCARBAZEPINE |
TABLET, EXTENDED RELEASE |
300MG |
No
|
No
|
2025/06/04
(TA)
|
--
|
NOVAST LABS LTD |
None (Tentative Approval) |
| OXCARBAZEPINE |
218724 |
003 |
ANDA |
OXCARBAZEPINE |
TABLET, EXTENDED RELEASE |
600MG |
No
|
No
|
2025/06/04
(TA)
|
--
|
NOVAST LABS LTD |
None (Tentative Approval) |
| OXCARBAZEPINE EXTENDED RELEASE TABLETS |
219404 |
002 |
ANDA |
OXCARBAZEPINE |
TABLET;EXTENDED RELEASE |
300MG |
No
|
No
|
2025/06/06
(TA)
|
--
|
LUPIN LIMITED |
None (Tentative Approval) |
| OXCARBAZEPINE EXTENDED RELEASE TABLETS |
219404 |
003 |
ANDA |
OXCARBAZEPINE |
TABLET;EXTENDED RELEASE |
600MG |
No
|
No
|
2025/06/06
(TA)
|
--
|
LUPIN LIMITED |
None (Tentative Approval) |
| OXCARBAZEPINE |
207300 |
001 |
ANDA |
OXCARBAZEPINE |
SUSPENSION;ORAL |
300MG/5ML |
No
|
No
|
2025/07/11
|
2025/07/11
|
MACLEODS PHARMS LTD |
Prescription |